ÂÜÀòÂÒÂ×

Dr. Stephanie Pond is the Vice President of Emerging Technologies at TGen and is focused on accelerating the adoption of new technologies into translational research and personalized medicine.

Prior to joining TGen, Dr. Pond worked on product development in diverse areas of research such as biophysics, genetics, oncology, forensic science, genetics assay development, and in different environments (academic, small start-up, large biotech company, CLIA laboratories). Her expertise in these areas has focused on method/technology development and the transfer of that technology to customers.

Dr. Pond received her BA in Chemistry and Physics from Westminster College and Ph.D. in Physical Chemistry from the University of Arizona.